AS Latvijas Juras medicinas centrs
Munich Stock ExchangeTotal Valuation
AS Latvijas Juras medicinas centrs carries a market capitalization of 5.92M, placing it among publicly traded companies globally.
| Market Cap | 5.92M |
| Enterprise Value | N/A |
Share Statistics
AS Latvijas Juras medicinas centrs currently has 800,000.00 shares outstanding.
| Shares Outstanding | 800,000.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
AS Latvijas Juras medicinas centrs trades at a trailing price-to-earnings ratio of 29.54. The price-to-sales ratio is 0.69, and the price-to-book ratio stands at 1.93.
| PE Ratio | 29.54 |
| PS Ratio | 0.69 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | 41.04 |
| P/OCF Ratio | -412.01 |
Financial Position
AS Latvijas Juras medicinas centrs maintains a current ratio of 0.86, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.86 |
| Quick Ratio | 0.63 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 6.68 |
| Return on Assets (ROA) | 2.71 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 6.68 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 72.60 |
Taxes
Over the trailing twelve months, AS Latvijas Juras medicinas centrs has paid 17,281.00 in income taxes, reflecting an effective tax rate of 6.69.
| Income Tax | 17,281.00 |
| Effective Tax Rate | 6.69 |
Stock Price Statistics
AS Latvijas Juras medicinas centrs's stock has gained approximately 22.31405% over the past 52 weeks. The 50-day moving average sits at 8.44, while the 200-day moving average is 7.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | 22.31405% |
| 50-Day Moving Average | 8.44 |
| 200-Day Moving Average | 7.08 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, AS Latvijas Juras medicinas centrs generated 10.29M in revenue and converted that into 240,996.00 in net income, yielding earnings per share of 0.30. EBITDA reached 113,253.00, while operating income came in at 113,253.00.
| Revenue | 10.29M |
| Gross Profit | 733,853.00 |
| Operating Income | 113,253.00 |
| Pretax Income | 258,277.00 |
| Net Income | 240,996.00 |
| EBITDA | 113,253.00 |
| EBIT | 113,253.00 |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
Total book value stands at 3.69M, with working capital of -254,414.00 providing operational flexibility.
| Cash & Cash Equivalents | 1.15M |
| Total Debt | N/A |
| Net Debt | -1.15M |
| Equity (Book Value) | 3.69M |
| Book Value Per Share | 4.61 |
| Working Capital | -254,414.00 |
Cash Flow
AS Latvijas Juras medicinas centrs produced -17,281.00 in operating cash flow over the past twelve months. After subtracting -190,773.00 in capital expenditures, free cash flow totaled -208,054.00 - equivalent to -0.26 per share.
| Operating Cash Flow | -17,281.00 |
| Capital Expenditures | -190,773.00 |
| Free Cash Flow | -208,054.00 |
| FCF Per Share | -0.26 |
Margins
AS Latvijas Juras medicinas centrs operates with a gross margin of 7.13, reflecting its pricing power and cost economics. The operating margin of 1.10 and net profit margin of 2.34 provide insight into operational efficiency.
| Gross Margin | 7.13 |
| Operating Margin | 1.10 |
| Pretax Margin | 2.51 |
| Profit Margin | 2.34 |
| EBITDA Margin | 1.10 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.12 |
| FCF Yield | 2.44 |
Scores
AS Latvijas Juras medicinas centrs posts an Altman Z-Score of 3.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.38 |